Author:
Bascunana C.,El Helou J.,Rauch F.T.,Bardai G.,Glorieux F.H.,Riviere J-B.,Byers P.,Kaplan P.B.,Rosenblatt D.S.
Subject
Endocrinology,Genetics,Molecular Biology,Biochemistry,Endocrinology, Diabetes and Metabolism
Reference8 articles.
1. Lethal osteogenesis imperfecta resulting from a single nucleotide change in one human pro alpha(I) collagen allele;Cohn;Proc. Natl. Acad. Sci. U. S. A.,1986
2. Perinatal lethal osetogenesis imperfecta (OI type II): a biochemically heterogeneious disorder usually due to a new mutation in the genes for type I collagen;Byers;Am. J. Hum. Genet.,1988
3. Recurrence of lethal osteogenesis imperfecta due to parental mosaicism for a dominant mutation in a human type I collagen gene (COL1A1);Cohn;Am. J. Hum. Genet.,1990
4. Recurrence of lethal osteogenesis imperfecta due to parental mosaicism for a mutation in the COL1A2 gene of type I collagen. The mosaic parent exhibits phenotypic features of a mild form of the disease;Edwards;Hum. Mutat.,1992
5. Targeted sequencing of a pediatric metabolic bone gene panel using a desktop semiconductor next-generation sequencer;Rauch;Calcif Tissue Int,2014